Cargando…

Randomised controlled trial of a new palliative care service: Compliance, recruitment and completeness of follow-up

BACKGROUND: Palliative care has been proposed for progressive non-cancer conditions but there have been few evaluations of service developments. We analysed recruitment, compliance and follow-up data of a fast track (or wait list control) randomised controlled trial of a new palliative care service...

Descripción completa

Detalles Bibliográficos
Autores principales: Higginson, Irene J, Hart, Sam, Burman, Rachel, Silber, Eli, Saleem, Tariq, Edmonds, Polly
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2442830/
https://www.ncbi.nlm.nih.gov/pubmed/18507817
http://dx.doi.org/10.1186/1472-684X-7-7
_version_ 1782156732009545728
author Higginson, Irene J
Hart, Sam
Burman, Rachel
Silber, Eli
Saleem, Tariq
Edmonds, Polly
author_facet Higginson, Irene J
Hart, Sam
Burman, Rachel
Silber, Eli
Saleem, Tariq
Edmonds, Polly
author_sort Higginson, Irene J
collection PubMed
description BACKGROUND: Palliative care has been proposed for progressive non-cancer conditions but there have been few evaluations of service developments. We analysed recruitment, compliance and follow-up data of a fast track (or wait list control) randomised controlled trial of a new palliative care service – a design not previously used to assess palliative care. METHODS/DESIGN: An innovative palliative care service (comprising a consultant in palliative medicine, a clinical nurse specialist, an administrator and a psychosocial worker) was delivered to people severely affected by multiple sclerosis (MS), and their carers, in southeast London. Our design followed the MRC Framework for the Evaluation of Complex Interventions. In phase II we conducted randomised controlled trial, of immediate referral to the service (fast-track) versus a 12-week wait (standard best practice). Main outcome measures were: compliance (the extent the trial protocol was adhered to), recruitment (target 50 patients), attrition and missing data rates; trial outcomes were Palliative Care Outcome Scale and MS Impact Scale. RESULTS: 69 patients were referred, 52 entered the trial (26 randomised to each arm), 5 refused consent and 12 were excluded from the trial for other reasons, usually illness or urgent needs, achieving our target numbers. 25/26 fast track and 21/26 standard best practice patients completed the trial, resulting in 217/225 (96%) of possible interviews completed, 87% of which took place in the patient's home. Main reasons for failure to interview and/or attrition were death or illness. There were three deaths in the standard best practice group and one in the fast-track group during the trial. At baseline there were no differences between groups. Missing data for individual questionnaire items were small (median 0, mean 1–5 items out of 56+ items per interview), not associated with any patient or carer characteristics or with individual questionnaires, but were associated with interviewer. CONCLUSION: This is the first time a fast track (or wait list) randomised trial has been reported in palliative care. We found it achieved good recruitment and is a feasible method to evaluate palliative care services when patients are expected to live longer than 3–6 months. Home interviews are needed for a trial of this kind; interviewers need careful recruitment, training and supervision; and there should be careful separation from the clinical service of the control patients to prevent accidental contamination. TRIAL REGISTRATION: Clinical Trials.Gov NCT00364963
format Text
id pubmed-2442830
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-24428302008-07-03 Randomised controlled trial of a new palliative care service: Compliance, recruitment and completeness of follow-up Higginson, Irene J Hart, Sam Burman, Rachel Silber, Eli Saleem, Tariq Edmonds, Polly BMC Palliat Care Research Article BACKGROUND: Palliative care has been proposed for progressive non-cancer conditions but there have been few evaluations of service developments. We analysed recruitment, compliance and follow-up data of a fast track (or wait list control) randomised controlled trial of a new palliative care service – a design not previously used to assess palliative care. METHODS/DESIGN: An innovative palliative care service (comprising a consultant in palliative medicine, a clinical nurse specialist, an administrator and a psychosocial worker) was delivered to people severely affected by multiple sclerosis (MS), and their carers, in southeast London. Our design followed the MRC Framework for the Evaluation of Complex Interventions. In phase II we conducted randomised controlled trial, of immediate referral to the service (fast-track) versus a 12-week wait (standard best practice). Main outcome measures were: compliance (the extent the trial protocol was adhered to), recruitment (target 50 patients), attrition and missing data rates; trial outcomes were Palliative Care Outcome Scale and MS Impact Scale. RESULTS: 69 patients were referred, 52 entered the trial (26 randomised to each arm), 5 refused consent and 12 were excluded from the trial for other reasons, usually illness or urgent needs, achieving our target numbers. 25/26 fast track and 21/26 standard best practice patients completed the trial, resulting in 217/225 (96%) of possible interviews completed, 87% of which took place in the patient's home. Main reasons for failure to interview and/or attrition were death or illness. There were three deaths in the standard best practice group and one in the fast-track group during the trial. At baseline there were no differences between groups. Missing data for individual questionnaire items were small (median 0, mean 1–5 items out of 56+ items per interview), not associated with any patient or carer characteristics or with individual questionnaires, but were associated with interviewer. CONCLUSION: This is the first time a fast track (or wait list) randomised trial has been reported in palliative care. We found it achieved good recruitment and is a feasible method to evaluate palliative care services when patients are expected to live longer than 3–6 months. Home interviews are needed for a trial of this kind; interviewers need careful recruitment, training and supervision; and there should be careful separation from the clinical service of the control patients to prevent accidental contamination. TRIAL REGISTRATION: Clinical Trials.Gov NCT00364963 BioMed Central 2008-05-28 /pmc/articles/PMC2442830/ /pubmed/18507817 http://dx.doi.org/10.1186/1472-684X-7-7 Text en Copyright © 2008 Higginson et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Higginson, Irene J
Hart, Sam
Burman, Rachel
Silber, Eli
Saleem, Tariq
Edmonds, Polly
Randomised controlled trial of a new palliative care service: Compliance, recruitment and completeness of follow-up
title Randomised controlled trial of a new palliative care service: Compliance, recruitment and completeness of follow-up
title_full Randomised controlled trial of a new palliative care service: Compliance, recruitment and completeness of follow-up
title_fullStr Randomised controlled trial of a new palliative care service: Compliance, recruitment and completeness of follow-up
title_full_unstemmed Randomised controlled trial of a new palliative care service: Compliance, recruitment and completeness of follow-up
title_short Randomised controlled trial of a new palliative care service: Compliance, recruitment and completeness of follow-up
title_sort randomised controlled trial of a new palliative care service: compliance, recruitment and completeness of follow-up
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2442830/
https://www.ncbi.nlm.nih.gov/pubmed/18507817
http://dx.doi.org/10.1186/1472-684X-7-7
work_keys_str_mv AT higginsonirenej randomisedcontrolledtrialofanewpalliativecareservicecompliancerecruitmentandcompletenessoffollowup
AT hartsam randomisedcontrolledtrialofanewpalliativecareservicecompliancerecruitmentandcompletenessoffollowup
AT burmanrachel randomisedcontrolledtrialofanewpalliativecareservicecompliancerecruitmentandcompletenessoffollowup
AT silbereli randomisedcontrolledtrialofanewpalliativecareservicecompliancerecruitmentandcompletenessoffollowup
AT saleemtariq randomisedcontrolledtrialofanewpalliativecareservicecompliancerecruitmentandcompletenessoffollowup
AT edmondspolly randomisedcontrolledtrialofanewpalliativecareservicecompliancerecruitmentandcompletenessoffollowup